Variant report
Variant | esv3408988 |
---|---|
Chromosome Location | chr2:56746148-56749446 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574647524 | chr2:56746201-56746202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376628098 | chr2:56746203-56746204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552018442 | chr2:56746215-56746216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543363552 | chr2:56746308-56746309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556696038 | chr2:56746323-56746324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576841908 | chr2:56746331-56746332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545890999 | chr2:56746355-56746356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183630364 | chr2:56746364-56746365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2162025 | chr2:56746396-56746397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs142103790 | chr2:56746404-56746405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76645854 | chr2:56746427-56746428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534147783 | chr2:56746442-56746443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114376685 | chr2:56746459-56746460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145981866 | chr2:56746476-56746477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10490407 | chr2:56746524-56746525 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs569930841 | chr2:56746585-56746586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139864466 | chr2:56746608-56746609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552243177 | chr2:56746626-56746627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9309282 | chr2:56746631-56746632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs534463768 | chr2:56746632-56746633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144903667 | chr2:56746658-56746659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs10170067 | chr2:56746660-56746661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181159209 | chr2:56746679-56746680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199507854 | chr2:56746683-56746684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10204808 | chr2:56746685-56746686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200057995 | chr2:56746708-56746709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200295157 | chr2:56746709-56746710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10204816 | chr2:56746710-56746711 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs576889541 | chr2:56746713-56746714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201683097 | chr2:56746733-56746734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557987204 | chr2:56746735-56746736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201038259 | chr2:56746758-56746759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79153505 | chr2:56746781-56746782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62161638 | chr2:56746788-56746789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs62161639 | chr2:56746792-56746793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201694489 | chr2:56746796-56746797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375016729 | chr2:56746797-56746798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142712406 | chr2:56746798-56746799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572986428 | chr2:56746810-56746811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541606385 | chr2:56746813-56746814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142105014 | chr2:56746821-56746822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561345660 | chr2:56746826-56746827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs575005324 | chr2:56746840-56746841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543744264 | chr2:56746853-56746854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540216140 | chr2:56746864-56746865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564051100 | chr2:56746926-56746927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532367014 | chr2:56746936-56746937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150997462 | chr2:56746946-56746947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560337293 | chr2:56746967-56746968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142176261 | chr2:56747000-56747001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56746000-56746600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr2:56746600-56749600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:56746800-56747800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr2:56747000-56747400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr2:56747000-56747400 | Enhancers | HSMM | muscle |
6 | chr2:56747200-56748000 | Enhancers | Adipose Nuclei | Adipose |
7 | chr2:56747400-56749600 | Weak transcription | HSMM | muscle |
8 | chr2:56747400-56749800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr2:56747800-56749800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr2:56748000-56750200 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr2:56748800-56752600 | Enhancers | Fetal Heart | heart |